BACKGROUND
This study explores the integration of 'Bioceramic Resonance and Photoluminescence' (BR&PLB) with a Visual/Auditory Thematic Stimulation System (VASS) to address stress, mental imbalances, and altered states.
OBJECTIVE
Against Taiwan's evolving economic landscape, conventional medical systems often struggle to address health complexities.
METHODS
The material and methods section elucidates BIOCERAMIC technology's biophysical effects and PLB development, highlighting VASS's use with thematic stimuli for enhancement. Twenty-five participants, aged 18 to 80, sought relief from pain, emotional distress, or desired self-awareness.
RESULTS
The experimental protocol involved BR&PLB with VASS exposure, assessing improvements in physical, emotional, and consciousness states. Statistical analyses revealed reductions in pain and anxiety, with consciousness level increases post-exposure.
CONCLUSIONS
Discussion integrates prior research, emphasizing technology's impact on altered consciousness and therapeutic potential for mental health. Insights from emotional problems, drug withdrawal, and extrasensory perception studies add to understanding. Comparisons with virtual reality studies highlight BR&PLB and VASS integration advantages. This approach shows promise for reducing pain, stress, anxiety, and enhancing consciousness levels, though further research is needed for validation. Combining BR&PLB with VASS could be a significant pathway to overall well-being.
The integration of BR&PLB with VASS demonstrates stress reduction, anxiety alleviation, and heightened consciousness levels. This approach emerges as a valuable intervention for comprehensive well-being, requiring larger-scale studies for validation. The exploration positions it as a noteworthy pathway in holistic well-being pursuit. Considered within the ‘States of Consciousness Questionnaire’ framework, the integrated approach facilitates physical improvement, emotional well-being, and nuanced consciousness shifts, offering a holistic perspective and emphasizing multifaceted benefits.
CLINICALTRIAL
The study protocol received approval from the Human Subjects Committee (approval no.: TYGH111092) of Taoyuan General Hospital